KEGG   PATHWAY: hmh04934
Entry
hmh04934                    Pathway                                
Name
Cushing syndrome - Hylobates moloch (silvery gibbon)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
hmh04934  Cushing syndrome
hmh04934

Organism
Hylobates moloch (silvery gibbon) [GN:hmh]
Gene
116813235  CRH; corticoliberin [KO:K05256]
116475000  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
116812597  CRHR2; corticotropin-releasing factor receptor 2 isoform X2 [KO:K04579]
116812065  guanine nucleotide-binding protein G(s) subunit alpha [KO:K04632]
116463273  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
116463274  neuroendocrine secretory protein 55 [KO:K04632]
116463360  guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
116463361  neuroendocrine secretory protein 55 [KO:K04632]
116812469  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
116457100  ADCY2; LOW QUALITY PROTEIN: adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
116480405  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
116484980  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
116466852  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
116461805  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
116471246  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
116813595  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
116462297  ADCY9; adenylate cyclase type 9 isoform X2 [KO:K08049] [EC:4.6.1.1]
116458418  PRKACG; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
116469844  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
116478588  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
116810385  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X3 [KO:K05870]
116810639  ATF2; cyclic AMP-dependent transcription factor ATF-2 [KO:K04450]
116458613  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
116810327  LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-4-like [KO:K04374]
116476303  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
116469376  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
116814406  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
116483538  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
116475074  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
116812715  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X5 [KO:K09047]
116460313  cyclic AMP-dependent transcription factor ATF-6 beta-like [KO:K09049]
116468969  MEN1; menin [KO:K14970]
116462018  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
116457535  RBBP5; retinoblastoma-binding protein 5 [KO:K14961]
116475837  WDR5; WD repeat-containing protein 5 [KO:K14963]
116466866  WDR5B; WD repeat-containing protein 5B [KO:K14963]
116477013  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
116461666  KMT2D; histone-lysine N-methyltransferase 2D isoform X8 [KO:K09187] [EC:2.1.1.354]
116473141  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
116458432  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
116458431  cyclin-dependent kinase inhibitor 2A [KO:K06621]
116480850  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
116814109  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
116469117  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
116467261  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
116461337  E2F1; transcription factor E2F1 [KO:K17454]
116813063  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
116459750  E2F3; transcription factor E2F3 isoform X2 [KO:K06620]
116483042  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
116469652  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
116464223  guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
116464225  guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
116814165  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
116813383  AHR; aryl hydrocarbon receptor [KO:K09093]
116458833  AIPL1; aryl-hydrocarbon-interacting protein-like 1 isoform X3 [KO:K17767]
116469085  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
116469474  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
116472702  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
116480938  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
116478827  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
116813431  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
116460475  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
116472525  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
116473372  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X9 [KO:K04851]
116811686  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
116457338  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
116459675  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
116471714  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
116812488  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
116463099  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2 [KO:K04515] [EC:2.7.11.17]
116469612  RAP1A; ras-related protein Rap-1A [KO:K04353]
116478979  RAP1B; ras-related protein Rap-1b [KO:K07836]
116814428  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
116482295  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
116814342  dual specificity mitogen-activated protein kinase kinase 2-like [KO:K04369] [EC:2.7.12.2]
116483548  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
116459126  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
116470222  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
116461658  NR4A1; nuclear receptor subfamily 4 group A member 1 isoform X1 [KO:K04465]
116812436  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
116481435  USP8; ubiquitin carboxyl-terminal hydrolase 8 isoform X1 [KO:K11839] [EC:3.4.19.12]
116480413  POMC; pro-opiomelanocortin [KO:K05228]
116468126  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
116481794  MRAP; melanocortin-2 receptor accessory protein isoform X1 [KO:K22398]
116471082  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X7 [KO:K18437] [EC:3.1.4.53]
116481464  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
116810611  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
116465006  steroidogenic factor 1 [KO:K08560]
116465007  steroidogenic factor 1 [KO:K08560]
116481003  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
116473306  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
116465197  cytochrome P450 11B1, mitochondrial [KO:K00497] [EC:1.14.15.4]
116465198  cytochrome P450 11B2, mitochondrial [KO:K00497] [EC:1.14.15.4]
116484149  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
116462019  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
116481249  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
116471197  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
116457859  AGT; angiotensinogen [KO:K09821]
116480239  AGTR1; type-1 angiotensin II receptor [KO:K04166]
116475178  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
116483096  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
116468938  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
116461202  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
116461370  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X2 [KO:K05858] [EC:3.1.4.11]
116481969  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X6 [KO:K05858] [EC:3.1.4.11]
116466681  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
116472793  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
116459671  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
116457712  KCNK2; potassium channel subfamily K member 2 [KO:K04913]
116474359  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X5 [KO:K04854]
116462356  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H isoform X1 [KO:K04855]
116458615  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I isoform X1 [KO:K04856]
116477786  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
116476402  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
116480448  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
116478469  LDLR; low-density lipoprotein receptor [KO:K12473]
116477710  SCARB1; scavenger receptor class B member 1 isoform X4 [KO:K13885]
116481899  cholesterol side-chain cleavage enzyme, mitochondrial [KO:K00498] [EC:1.14.15.6]
116469522  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
116469530  HSD3B2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 isoform X1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
116460301  steroid 21-hydroxylase [KO:K00513] [EC:1.14.14.16]
116457929  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
116462014  WNT1; proto-oncogene Wnt-1 [KO:K03209]
116469600  WNT2B; protein Wnt-2b [KO:K00182]
116814280  WNT2; protein Wnt-2 [KO:K00182]
116458095  WNT3A; protein Wnt-3a [KO:K00312]
116474164  WNT3; proto-oncogene Wnt-3 [KO:K00312]
116813045  WNT4; protein Wnt-4 [KO:K00408]
116472519  WNT5B; protein Wnt-5b [KO:K00444]
116473363  WNT5A; protein Wnt-5a [KO:K00444]
116810282  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
116458970  WNT7B; protein Wnt-7b [KO:K00572]
116466764  WNT7A; protein Wnt-7a [KO:K00572]
116485066  WNT8B; protein Wnt-8b [KO:K00714]
116470472  WNT8A; protein Wnt-8a isoform X1 [KO:K00714]
116458096  WNT9A; protein Wnt-9a [KO:K01064]
116474162  WNT9B; protein Wnt-9b [KO:K01064]
116810281  WNT10A; protein Wnt-10a [KO:K01357]
116462013  WNT10B; protein Wnt-10b [KO:K01357]
116477384  WNT11; protein Wnt-11 [KO:K01384]
116814291  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
116810440  FZD7; frizzled-7 [KO:K02432]
116814122  FZD1; frizzled-1 [KO:K02432]
116474949  FZD2; frizzled-2 [KO:K02235]
116461764  FZD3; frizzled-3 [KO:K02329]
116476785  FZD4; frizzled-4 [KO:K02354]
116480936  FZD8; frizzled-8 [KO:K02375]
116810383  FZD5; frizzled-5 [KO:K02375]
116813496  FZD6; frizzled-6 isoform X1 [KO:K02376]
116479382  FZD10; frizzled-10 [KO:K02842]
116811758  FZD9; frizzled-9 [KO:K02842]
116479887  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
116459316  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
116812776  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
116466895  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
116462417  AXIN1; axin-1 isoform X1 [KO:K02157]
116463760  axin-2 isoform X1 [KO:K04385]
116463765  axin-2 isoform X1 [KO:K04385]
116473623  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
116483925  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
116470936  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
116471505  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
116483590  TCF7L1; transcription factor 7-like 1 isoform X2 [KO:K04490]
116483446  TCF7L2; transcription factor 7-like 2 isoform X12 [KO:K04491]
116479176  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
hmh00020  Citrate cycle (TCA cycle)
hmh00140  Steroid hormone biosynthesis
hmh04020  Calcium signaling pathway
hmh04024  cAMP signaling pathway
hmh04110  Cell cycle
hmh04310  Wnt signaling pathway
hmh04927  Cortisol synthesis and secretion
hmh04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system